...
【24h】

Determination of mirtazapine in tablets by UV spectrophotometric and derivative spectrophotometric methods.

机译:紫外分光光度法和导数分光光度法测定片剂中的米氮平。

获取原文
获取原文并翻译 | 示例
           

摘要

Mirtazapine, 1, 2, 3, 4, 10, 14b-hexahydro-2-methyl-pyrazino [2, 1-a] pyrido [2, 3-c] [G.L. Stimmel, J.A. Dopheide and S.M. Stahl, Pharmacotheraphy 17(1) (1997) 10] benzazepine, is a new and well tolerated antidepressant. It blocks pre-synaptic alpha2-adrenergic receptors and postsynaptic serotonin type 2 and type 3 receptors. The drug is rapid and completely absorbed after oral administration. Mirtazapine was analyzed by HPLC and gas chromatography with nitrogen-sensitive detection. In this study, mirtazapine was analyzed by using UV spectrophotometry, first and second order derivative spectrophotometry. The type of solvent, the degree of derivation, range of wavelength and n value were chosen in order to optimize the conditions. The concentration of mirtazapine in its methanolic solutions were determined between the wavelength range of 225-360 nm in the linearity range of 1-100, 2-100 and 1-120 microg ml(-1) by using the values obtained from UV. first-order derivative (n = 5, delta lambda = 17.5 nm) and second-order derivative (n = 9, delta lambda = 31.5 nm) spectrum of the substance, respectively. The developed UV Spectrophotometric, first-order and second-order derivative spectrophotometric methods were applied to a pharmaceutical preparation as tablet form. Developed UV and derivative UV spectrophotometric method in this study are accurate, sensitive, precise, reproducible and can be directly and easily applied to the pharmaceutical preparations.
机译:米氮平,1、2、3、4、10、14b-六氢-2-甲基-吡嗪并[2,1-a]吡啶基[2,3-c] [G.L. Stimmel,J.A。多菲德和S.M. Stahl,Pharmacotheraphy 17(1)(1997)10]苯并ze庚因是一种新的且耐受性良好的抗抑郁药。它阻断突触前α2-肾上腺素受体和突触后5-羟色胺2型和3型受体。口服后,该药物迅速,完全吸收。米氮平通过HPLC和气相色谱法进行氮敏感检测。在这项研究中,米氮平通过紫外分光光度法,一阶和二阶导数分光光度法进行了分析。选择溶剂的类型,衍生度,波长范围和n值以优化条件。使用从紫外线获得的值,测定米氮平在其甲醇溶液中的浓度,该波长在225-360 nm的波长范围内,线性范围为1-100、2-100和1-120 microg ml(-1)。物质的一阶导数(n = 5,δλ= 17.5 nm)和二阶导数(n = 9,δλ= 31.5 nm)光谱。将开发的紫外分光光度法,一阶和二阶导数分光光度法应用于片剂形式的药物制剂。本研究中开发的紫外和导数紫外分光光度法是准确,灵敏,精确,可重现的,可以直接轻松地用于药物制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号